AT330761B - Verfahren zur herstellung von neuen acylaminosaureamiden - Google Patents

Verfahren zur herstellung von neuen acylaminosaureamiden

Info

Publication number
AT330761B
AT330761B AT334474A AT334474A AT330761B AT 330761 B AT330761 B AT 330761B AT 334474 A AT334474 A AT 334474A AT 334474 A AT334474 A AT 334474A AT 330761 B AT330761 B AT 330761B
Authority
AT
Austria
Prior art keywords
acylaminosaureamides
preparation
new
new acylaminosaureamides
Prior art date
Application number
AT334474A
Other languages
English (en)
Other versions
ATA334474A (de
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of ATA334474A publication Critical patent/ATA334474A/de
Application granted granted Critical
Publication of AT330761B publication Critical patent/AT330761B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT334474A 1973-05-03 1974-04-23 Verfahren zur herstellung von neuen acylaminosaureamiden AT330761B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2322232A DE2322232A1 (de) 1973-05-03 1973-05-03 Neue acylaminosaeureamide

Publications (2)

Publication Number Publication Date
ATA334474A ATA334474A (de) 1975-10-15
AT330761B true AT330761B (de) 1976-07-26

Family

ID=5879881

Family Applications (1)

Application Number Title Priority Date Filing Date
AT334474A AT330761B (de) 1973-05-03 1974-04-23 Verfahren zur herstellung von neuen acylaminosaureamiden

Country Status (12)

Country Link
US (1) US3948943A (de)
JP (1) JPS5029754A (de)
AT (1) AT330761B (de)
BE (1) BE814476A (de)
CH (1) CH604704A5 (de)
DE (1) DE2322232A1 (de)
ES (1) ES425215A1 (de)
FR (1) FR2227874B1 (de)
GB (1) GB1445503A (de)
IL (1) IL44742A (de)
NL (1) NL7405324A (de)
NO (1) NO741580L (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017513A (en) * 1975-03-17 1977-04-12 Abbott Laboratories Method for making aminoacid amides
US4172149A (en) * 1978-01-30 1979-10-23 Westwood Pharmaceuticals, Inc. Method for treating living skin exhibiting excessive sebum secretion
US4220167A (en) * 1978-06-05 1980-09-02 Helene Curtis Industries, Inc. Method of restoring normal moisture level to hair with slight to moderate moisture deficiency
US4220168A (en) * 1978-06-05 1980-09-02 Helene Curtis Industries, Inc. Method of moisturizing and maintaining normal moisture level in hair having a normal moisture content
US4220166A (en) * 1978-06-05 1980-09-02 Helene Curtis Industries, Inc. Method of restoring normal moisture level to hair with severe moisture deficiency
US4374125A (en) * 1978-06-05 1983-02-15 Helene Curtis Industries, Inc. Hair moisturizing compositions
US4452989A (en) * 1982-06-01 1984-06-05 Charles Of The Ritz Group Ltd. Substantive moisturizing derivatives of 2-pyrrolidone-5-carboxylic acid and compositions containing same
US4590069A (en) * 1982-06-01 1986-05-20 Charles Of The Ritz Group Ltd. Novel substantive moisturizing derivatives of 2-pyrrolidone-5-carboxylic acid and compositions containing same
US4762704A (en) * 1983-06-22 1988-08-09 Bristol-Myers Company Antiperspirant compositions, containing certain antihistamines and certain antihistamine enhancers
DK255889D0 (da) * 1989-05-25 1989-05-25 Novo Nordisk As Fremgangsmaade til fremstilling af organiske forbindelser
DE4407193A1 (de) * 1994-03-04 1995-09-07 Asta Medica Ag Langkettige Alkylamide von Aminosäuren und Peptiden mit antiproliferativen und entzündungshemmenden Eigenschaften
DE19828643A1 (de) * 1998-06-26 1999-12-30 Wella Ag Einphasiges, schaumförmiges Haarbehandlungsmittel zur Erzielung eines Pomadeneffektes
US6667045B2 (en) 1999-10-01 2003-12-23 Joseph Scott Dahle Topical applications for skin treatment
FR2826263B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un compose anti-inflammatoire
FR2826265B1 (fr) * 2001-06-26 2005-02-18 Oreal Composition cosmetique ou dermatologique comprenant une association entre un inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un agent antifongique et/ou antibacterien
FR2826267B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un agent myorelaxant
CA2753318A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Substituted pyrrole derivatives
SG166829A1 (en) * 2005-11-08 2010-12-29 Ranbaxy Lab Ltd Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US20070238716A1 (en) * 2006-03-14 2007-10-11 Murthy Ayanampudi S R Statin stabilizing dosage formulations
WO2008010087A2 (en) * 2006-07-14 2008-01-24 Ranbaxy Laboratories Limited Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
DE102014110783A1 (de) * 2014-07-30 2016-02-04 Eberhard Karls Universität Tübingen Medizinische Fakultät Zusammensetzung zur Modulation der Aktivität von Nicht-Strukturproteinen
US20180250292A1 (en) * 2015-09-04 2018-09-06 Indiana University Research And Technology Corporation Antibiotic gel formulation and methods of preparing the antibiotic gel formulation

Also Published As

Publication number Publication date
NL7405324A (de) 1974-11-05
AU6849774A (en) 1975-11-06
IL44742A0 (en) 1974-07-31
NO741580L (no) 1974-11-05
FR2227874B1 (de) 1977-11-10
US3948943A (en) 1976-04-06
JPS5029754A (de) 1975-03-25
DE2322232A1 (de) 1974-11-14
IL44742A (en) 1977-07-31
GB1445503A (en) 1976-08-11
ATA334474A (de) 1975-10-15
CH604704A5 (de) 1978-09-15
FR2227874A1 (de) 1974-11-29
ES425215A1 (es) 1976-05-16
BE814476A (fr) 1974-11-04

Similar Documents

Publication Publication Date Title
AT333726B (de) Verfahren zur herstellung von neuen n-cinnamoyl- oder hydrocinnamoylaminobenzoesauren
AT342793B (de) Verfahren zur herstellung von neuen cholesteranen
AT330761B (de) Verfahren zur herstellung von neuen acylaminosaureamiden
AT333953B (de) Verfahren zur herstellung von neuen 7-alpha-aminoacyl-3-halogencephalosporinen
AT337698B (de) Verfahren zur herstellung von neuen 2-hydroxyphenyl -1-oxa-4- azaspiro-alkan- derivaten
AT338246B (de) Verfahren zur herstellung von neuen 2-aminoalkanoylamidobenzophenonen
AT343292B (de) Verfahren zur herstellung von neuen steroid-3-oxim-derivaten
AT330161B (de) Verfahren zur herstellung von neuen biphenylbutanolen
AT348536B (de) Verfahren zur herstellung von neuen 4-oxo-2- imidazolidinylidenharnstoffen
AT337201B (de) Verfahren zur herstellung von neuen 5-phenylsulfinylbenzimidazolyl-2-carbaminsaurealkylestern
AT339283B (de) Verfahren zur herstellung von neuen 3,4-diamino-benzophenonen
AT335449B (de) Verfahren zur herstellung von neuen thiadiazolylimidazolidinonen
AT341509B (de) Verfahren zur herstellung von neuen chloracetaniliden
AT331780B (de) Verfahren zur herstellung von neuen 3-n-butylamino-4-phenoxy-5-alkoxymethyl-sulfamoylbenzoesauren
AT327950B (de) Verfahren zur herstellung von neuen 1,2-oxaphospholanen
AT325059B (de) Verfahren zur herstellung von neuen thiazolotriazolylphosphonothioaten
AT343685B (de) Verfahren zur herstellung von neuen d-xylofuranose-derivaten
ATA695076A (de) Verfahren zur herstellung von neuen 5-methyl-7-hydroxy-isoflavon-derivaten
ATA722375A (de) Verfahren zur herstellung von neuen 3-n-butylamino-4-phenoxy-5-alkoxymethyl-sulfamoylbenzoesauren
ATA722475A (de) Verfahren zur herstellung von neuen 3-n-butylamino- 4-phenoxy-5 -alkoxymethyl-sulfamoylbenzoesauren
ATA895275A (de) Verfahren zur herstellung von neuen derivaten des digitoxigenin-alfa-l-arabinosids
ATA895175A (de) Verfahren zur herstellung von neuen derivaten des digitoxigenin-alfa-l-arabinosids
AT341502B (de) Verfahren zur herstellung von neuen 3,4-diamino-benzophenonen
ATA691775A (de) Verfahren zur herstellung von neuen 1,1-diphenyl -2-hydroxy-3- aminopropanderivaten
ATA746976A (de) Verfahren zur herstellung von neuen 3,4-diamino-benzophenonen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee